J E Varhaug
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
J E Varhaug has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- D. C. Anderson
Biosciences Division, SRI International, Harrisonburg, VA 22802, USA
1 shared publication - Darina Gromyko
Department of Surgery, Haukeland University Hospital, N-5021 Bergen, Norway
1 shared publication - Diane Kagabo
Department of Molecular Biology, University of Bergen, N-5020 Bergen, Norway
1 shared publication - Johan Richard Lillehaug
Department of Molecular Biology, University of Bergen, Bergen, Norway
1 shared publication - Kristian K. Starheim
CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway
1 shared publication - Matthew J. Betts
Cell Networks, Bioquant, University of Heidelberg, Heidelberg, Germany
1 shared publication
Latest Publications
- 1 October 2010
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 97 (11) , 1685-1686
Long-term results of surgery for lithium-associated hyperparathyroidism (Br J Surg 2010; 97:1680–1685)
- 1 October 2010
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 97 (11) , 1685-1686
Long-term results of surgery for lithium-associated hyperparathyroidism (Br J Surg 2010; 97:1680–1685)
- Open Access
- 1 January 2009
- Published by Springer Nature in BMC Biochemistry
- Vol. 10 (1) , 15
A novel human NatA Nα-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1)
Protein acetylation is among the most common protein modifications. The two major types are post-translational Nε-lysine acetylation catalyzed by KATs (Lysine acetyltransferases, previously named HATs (histone acetyltransferases) and co-translational Nα-terminal acetylation catalyzed by NATs (N-terminal acetyltransferases). The major NAT complex in yeast, NatA, is composed of the catalytic subunit Naa10p (N alpha acetyltransferase 10 protein) (Ard1p) and the auxiliary subunit Naa15p (Nat1p). The NatA complex potentially acetylates Ser-, Ala-, Thr-, Gly-, Val- and Cys- N-termini after Met-cleavage. In humans, the homologues hNaa15p (hNat1) and hNaa10p (hArd1) were demonstrated to form a stable ribosome associated NAT complex acetylating NatA type N-termini in vitro and in vivo.
- 1 January 2009
- Published by Springer Nature in BMC Biochemistry
- Vol. 10 (1) , 15
Open AccessA novel human NatA Nα-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1)
Protein acetylation is among the most common protein modifications. The two major types are post-translational Nε-lysine acetylation catalyzed by KATs (Lysine acetyltransferases, previously named HATs (histone acetyltransferases) and co-translational Nα-terminal acetylation catalyzed by NATs (N-terminal acetyltransferases). The major NAT complex in yeast, NatA, is composed of the catalytic subunit Naa10p (N alpha acetyltransferase 10 protein) (Ard1p) and the auxiliary subunit Naa15p (Nat1p). The NatA complex potentially acetylates Ser-, Ala-, Thr-, Gly-, Val- and Cys- N-termini after Met-cleavage. In humans, the homologues hNaa15p (hNat1) and hNaa10p (hArd1) were demonstrated to form a stable ribosome associated NAT complex acetylating NatA type N-termini in vitro and in vivo.